Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Bannwarth

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|April 11, 2013
A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritisBernard Bannwarth, Marie Kostine, Nicolas Poursac
Joint Bone Spine|September 28, 2011
Nonspecific low back pain: assessment of available medicationsBernard Bannwarth, Marie Kostine, Emilie Shipley
Joint Bone Spine|November 26, 2013
Are there concerns about generic medicines in rheumatology?Bernard Bannwarth, Marie Kostine, Nicolas Poursac
Fundamental & Clinical Pharmacology|January 30, 2004
Diffusion of arylpropionate non-steroidal anti-inflammatory drugs into the cerebrospinal fluid: a quantitative structure-activity relationship approachFabienne Péhourcq, Myriam Matoga, Bernard Bannwarth
Joint Bone Spine|November 13, 2012
Licensing of antirheumatic drugs: are the EMA and FDA on the same page?Bernard Bannwarth, Driss Berdaï, Marie Kostine
La Revue Du Praticien|May 24, 2014
[Bone fragility]Nicolas Poursac, Nadia Mehsen-Cêtre, Bernard Bannwarth
Therapie|October 18, 2016
Denosumab-induced severe hypocalcemia in a patient with Paget's disease of bone and impaired renal functionMarie Kostine, Nadia Mehsen-Cetre, Bernard Bannwarth
The Journal of Rheumatology|September 18, 2002
Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazoleBernard Bannwarth, Etienne Dorval, Agnes Caekaert, et al.
Expert Opinion on Investigational Drugs|August 1, 2014
Atacicept as an investigated therapy for rheumatoid arthritisChristophe Richez, Marie-Elise Truchetet, Thierry Schaeverbeke, et al.
Expert Opinion on Pharmacotherapy|July 25, 2017
Efficacy of baricitinib in the treatment of rheumatoid arthritisChristophe Richez, Marie-Elise Truchetet, Marie Kostine, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Metabolism & Toxicology|April 11, 2013
A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritisBernard Bannwarth, Marie Kostine, Nicolas Poursac
Joint Bone Spine|September 28, 2011
Nonspecific low back pain: assessment of available medicationsBernard Bannwarth, Marie Kostine, Emilie Shipley
Joint Bone Spine|November 26, 2013
Are there concerns about generic medicines in rheumatology?Bernard Bannwarth, Marie Kostine, Nicolas Poursac
Fundamental & Clinical Pharmacology|January 30, 2004
Diffusion of arylpropionate non-steroidal anti-inflammatory drugs into the cerebrospinal fluid: a quantitative structure-activity relationship approachFabienne Péhourcq, Myriam Matoga, Bernard Bannwarth
Joint Bone Spine|November 13, 2012
Licensing of antirheumatic drugs: are the EMA and FDA on the same page?Bernard Bannwarth, Driss Berdaï, Marie Kostine
La Revue Du Praticien|May 24, 2014
[Bone fragility]Nicolas Poursac, Nadia Mehsen-Cêtre, Bernard Bannwarth
Therapie|October 18, 2016
Denosumab-induced severe hypocalcemia in a patient with Paget's disease of bone and impaired renal functionMarie Kostine, Nadia Mehsen-Cetre, Bernard Bannwarth
The Journal of Rheumatology|September 18, 2002
Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazoleBernard Bannwarth, Etienne Dorval, Agnes Caekaert, et al.
Expert Opinion on Investigational Drugs|August 1, 2014
Atacicept as an investigated therapy for rheumatoid arthritisChristophe Richez, Marie-Elise Truchetet, Thierry Schaeverbeke, et al.
Expert Opinion on Pharmacotherapy|July 25, 2017
Efficacy of baricitinib in the treatment of rheumatoid arthritisChristophe Richez, Marie-Elise Truchetet, Marie Kostine, et al.
Pageof 6